New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2014
11:09 EDTKSU, GGB, TEVA, MYLOptions with increasing implied volatility: GGB MYL TEVA KSU
News For GGB;MYL;TEVA;KSU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 19, 2015
06:08 EDTTEVA, MYLPerrigo CEO says would talk with Mylan, but at a higher price, Globes reports
Subscribe for More Information
May 18, 2015
12:07 EDTMYLPerrigo: there is price point where would engage with Mylan, Bloomberg reports
Subscribe for More Information
10:01 EDTKSUOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:56 EDTKSUKansas City Southern downgraded due to lower volumes at BofA/Merrill
As previously reported, BofA/Merrill downgraded Kansas City Southern to Neutral from Buy and lowered its price target to $97 from $116. The firm said Kansas City Southern already pulled guidance and Q2 carloads to date are down 7%, versus its 1% growth forecast and coal carloads are down 44%, below its forecast of down 7%, due to large customer. Luminent, being virtually shut-down due to low natural gas prices.
07:22 EDTMYLUBS to hold a conference
Global Healthcare Conference is being held in New York on May 18-20 with webcasted company presentations to begin on May 18 at 8 am; not all company presentations may be webcasted. Webcast Link
06:47 EDTKSUKansas City Southern downgraded to Neutral from Buy at BofA/Merrill
May 15, 2015
17:08 EDTTEVASoros Fund gives quarterly update on stakes
Subscribe for More Information
14:51 EDTMYLMylan ANDA for generic version of Lexapro approved by FDA
The ANDA from Mylan (MYL) for a generic version of Escitalopram Oxalate, which is sold under the trade name Lexapro by Actavis' (ACT) Forest Labs, was approved by the FDA on May 14, according to a post to the regulator's site. Reference Link
10:01 EDTKSUOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:31 EDTTEVA, MYLAmerican Thoracic Society to hold a conference
ATS 2015 Conference is being held in Denver on May 15-20.
08:12 EDTTEVATeva migraine treatment data positive, says Bernstein
Subscribe for More Information
08:04 EDTTEVATeva to present new respiratory data at 2015 ATS conference
Teva Pharmaceutical Industries announced that three company-sponsored abstracts will be presented at the 2015 American Thoracic Society International Conference in Denver, Colorado on May 15-19.Data to be presented include a Phase III study examining the functionality, reliability, accuracy and overall patient satisfaction of ProAir RespiClick inhalation powder, which gained approval from the U.S. FDA in March 2015. ProAir RespiClick is now available by prescription and is indicated for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm in patients 12 years of age and older. Additional Phase III data to be presented include a late-breaking abstract highlighting an interim analysis of the long-term safety and efficacy of Teva’s investigational anti-IL-5 therapy, reslizumab, in patients with asthma and elevated blood eosinophils. A third abstract to be presented includes data from a dose-ranging study of fluticasone propionate multi-dose, dry-powder inhaler in adolescent and adult patients with asthma.
07:31 EDTKSUKansas City Southern downgraded at Credit Suisse
Subscribe for More Information
06:09 EDTKSUKansas City Southern downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information
May 14, 2015
09:19 EDTKSUKansas City Southern drops after withdrawing 2015 revenue, volume guidance
Subscribe for More Information
09:10 EDTKSUKansas City Southern to reevaluate providing revenue, volume guidance in 2016
Subscribe for More Information
09:05 EDTKSUKansas City Southern board authorizes $500M share repurchase program
Subscribe for More Information
09:05 EDTKSUKansas City Southern withdrawing 2015 revenue, volume guidance
On May 14, at the Bank of America Merrill Lynch Transportation Conference, Kansas City Southern EVP and CFO, Michael W. Upchurch, will provide a business update. As noted in Upchurch’s presentation, the company is withdrawing its 2015 revenue and volume guidance primarily due to the uncertainty around energy-related markets, foreign exchange impacts, and U.S. fuel prices. The company is reiterating its operating ratio target of low-60s by 2017.
08:35 EDTTEVATeva says data present case for TEV-48125 progression to Phase III
Subscribe for More Information
07:44 EDTTEVAInternational Headache Society to hold a conference
17th Congress of the International Headache Society is being held in Valencia, Spain on May 14-17.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use